News

Herramienta de IA supera a los operadores humanos de llamadas de emergencia en la identificación de ataque cerebrales, según un nuevo estudio

by

MÚNICH, 23 de mayo de 2023 /PRNewswire/ — Investigadores de Dinamarca han desarrollado una nueva herramienta de inteligencia artificial para hacer frente a la cantidad de ataques cerebrales que no son reconocidos por los operadores humanos de llamadas de emergencia. La herramienta superó a los operadores humanos de llamadas de emergencia en el reconocimiento de ataques … Read more

Selon une nouvelle étude, un outil d’IA réalise de meilleures performances que les gestionnaires d’appels d’urgence humains pour identifier les accidents vasculaires cérébraux

by

MUNICH, 24 mai 2023 /PRNewswire/ — Des chercheurs au Danemark ont mis au point un nouveau cadre d’intelligence artificielle (IA) pour traiter les accidents vasculaires cérébraux qui ne sont pas identifiés par les gestionnaires d’appels d’urgence humains. Le cadre a été plus performant que les gestionnaires d’appels d’urgence pour reconnaître les accidents vasculaires cérébraux des … Read more

AI tool outperforms human emergency call handlers in identifying stroke, new study shows

by

MUNICH, May 23, 2023 /PRNewswire/ — Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both sexes and across all age groups studied, indicating its potential as a supplementary tool … Read more

nuevo marco de inteligencia artificial

by

ESOC 2023: La herramienta de inteligencia artificial supera a los gestores de llamadas de emergencia humanos en la identificación de accidentes cerebrovasculares, según muestra un nuevo estudio MUNICH, 23 de mayo de 2023 /PRNewswire/ — Investigadores de Dinamarca han desarrollado un nuevo marco de inteligencia artificial (IA) para abordar la cantidad de infartos que no son … Read more

Growing Approvals for Cell-based Therapies Fuels the Sector

by

DUBLIN, May 23, 2023 /PRNewswire/ — The “Cell Therapy Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War” report has been added to  ResearchAndMarkets.com’s offering. The global cell therapy market is expected to grow at a CAGR of around 18.7% during 2023-2030. Companies Mentioned AlloSource Holostem Terapie … Read more

KI-Tool übertrifft menschliche Notrufmitarbeiter bei der Erkennung von Schlaganfällen

by

MÜNCHEN, 23. Mai 2023 /PRNewswire/ — Forscher aus Dänemark haben ein neues System für künstliche Intelligenz (KI) entwickelt, um die Zahl der Schlaganfälle zu verringern, die von menschlichen Notrufmitarbeitern unerkannt bleiben. Das System übertraf bei der Erkennung von Schlaganfällen bei beiden Geschlechtern und in allen untersuchten Altersgruppen die Leistung der Notrufabwickler, was darauf hindeutet, dass es … Read more

AI tool outperforms human emergency call handlers in identifying stroke, new study shows

by

MUNICH, May 23, 2023 /PRNewswire/ — Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both sexes and across all age groups studied, indicating its potential as a supplementary tool … Read more

PTC Therapeutics Announces Strategic Pipeline Prioritization

by

– Preclinical and early research gene therapy programs discontinued –– Expected reductions of approximately 15% in residual 2023 OPEX – SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the discontinuation of preclinical and early research programs in gene therapy as part of a strategic portfolio prioritization. PTC will continue … Read more

FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria

by

SILVER SPRING, Md., May 23, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex, for patients 18 years of age and older. According … Read more

Myeloid Therapeutics to Participate at SVB Securities Biopharma Company Connect Event

by

CAMBRIDGE, Mass., May 23, 2023 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the SVB Securities Biopharma Company Connect event, taking place virtually May 24th– 25th, 2023. Myeloid management will participate in virtual one-on-one meetings with investors during the event. About Myeloid Therapeutics Myeloid Therapeutics is … Read more